Skip to main content

PANAGORA ASSET MANAGEMENT INC

Position in ACAD — Acadia Pharmaceuticals Inc

CIK 883677 Boston, MA

Position in ACAD

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$15,329,326
-$2,862,908 QoQ
Shares Held
688,649
+1.1% QoQ
Ownership
0.402%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority Sole 11.533161305686932.ToString("F0")% Shared 0.ToString("F0")% None 88.46683869431307.ToString("F0")%

Common Shares in ACAD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

PANAGORA ASSET MANAGEMENT INC holds $504,243,073 across 65 Biotechnology names. ACAD ranks #9 (3.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ACAD

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $15,329,326 688,649
2025-12-31 $18,192,234 681,102
2025-09-30 $14,016,816 656,833
2025-06-30 $14,110,964 654,194
2025-03-31 $10,858,936 653,759
2024-12-31 $12,021,837 655,141
2024-09-30 $10,199,585 663,172
2024-06-30 $10,755,387 661,870
2024-03-31 $12,966,889 701,292
2023-12-31 $20,192,445 644,920
2023-09-30 $13,400,078 642,998
2023-06-30 $16,170,105 675,161
2023-03-31 $13,700,978 728,001
2022-12-31 $10,835,231 680,605
2022-09-30 $10,755,783 657,444
2022-06-30 $9,112,947 646,767
2022-03-31 $11,622,742 479,882
2021-12-31 $9,350,424 400,618
2021-09-30 $6,793,921 409,026
2021-06-30 $9,910,315 406,327
2021-03-31 $118,576 4,596
2020-06-30 $170,711 3,522
2020-03-31 $1,162,128 27,506